In May 2004, two groundwater wells in Dinwiddie County, Virginia were found to have natural uranium levels either at or above the EPA recommended limit of 30 mg/l. As a result, a stop drinking water advisory was issued until a water treatment system could be installed to remove the uranium. In response to residents' concerns, and uncertainty of exposures, affected individuals were asked to participate in a voluntary epidemiological investigation of uranium uptake and 1-year uranium retention study. This study had two primary objectives: quantification of the uranium load on the participants, as expressed by their urine uranium concentration, and retention after 1 year of no exposure. A first-morning void urine specimen, along with survey information, was collected from 156 participants in May 2004, with a second collection occurring 12 months later of 91 participants. The samples were analyzed for uranium by ICP/MS, pH, creatinine by the Jaffe method, and RBP by LIA after both collections. A reduction of one order of magnitude for the geometric mean urine uranium concentration was observed, from 0.100 mg/g creatinine to 0.011 mg/g creatinine in 1 year. Comparatively, NHANES has reported that the geometric mean for all participants, ages 6 years and older, is 0.008 mg/g creatinine, with the 95th percentile being 0.040 mg/g creatinine. None of the second round specimens showed a urine uranium concentration higher than baseline for an individual.
Introduction
Uranium is a pervasive element in the Earth's crust and under the appropriate conditions can become soluble and contaminate a region's groundwater (Kurttio et al., 2002; Al-Jundi et al., 2004) . When ingested at high levels over extended periods of time, uranium can cause functional and histological damage to the proximal tubule of the kidneys (CDC, 2001 (CDC, -2002 . Damage to the kidneys comes from the chemical aspects of uranium being a toxic metal, not the radiation hazard, which is negligible. Following exposure to soluble uranium salts, the initial half-life of uranium is considered to be about 15 days. The Environmental Protection Agency (EPA) established a Maximum Contamination Level (MCL) of 30 mg/l of uranium in drinking water (Kim et al., 2004 , Orloff et al., 2004 . Toxic effects to the kidneys have been reported at drinking-water concentrations Z300 mg/l uranium as shown by an early indicator of damage, namely retinol-binding protein (RBP) output in urine.
The investigation took place in Dinwiddie County, south central Virginia in 2004 and 2005 (Figure 1 ). The two wells involved supplied water through a community system for two adjacent subdivisions. The first well, drilled in 1976 to a depth of 405 ft, supplied all of the water for the subdivisions until 1980. In 1980 well number 2 was drilled to accommodate the increased demand for water from additional households. Well number 2 was drilled to a depth of 565 ft. Before May 2004, water from each well was delivered to the subdivisions in closed systems so that no mixing occurred. Well number 1 supplied about 80% of the households, while well number 2 supplied the remaining 20%. After May 2004, water from the two wells was blended before delivery to the subdivisions in an effort to reduce the uranium concentration of the water.
Testing of the two wells for radionuclides began in 1980; results for the testing conducted are summarized in Table 1 . Under the EPA's guidelines of the time, the well water was screened for uranium, radon, and radium by measuring gross alpha particle activity. When gross alpha levels exceeded 15 pCi/l, specific testing for uranium was performed. Well number 1 exceeded this level of gross alpha activity several times between 1980 and 2004, but as no limit on uranium concentration had been set, no action was taken to reduce the levels. On 7 December 2003 the EPA promulgated the new MCL of 30 mg/l for uranium, giving existing well systems several years to come into compliance.
In 2004, three residents of the community were found to have elevated uranium levels in hair samples. Private testing of the water at the home of one resident, determined that the natural uranium levels were either at or more than two times above the EPA MCL. The test results raised community concerns that their drinking water supply was contaminated with dangerously high levels of uranium. The likely source of contamination is thought to be uranium deposits in granite formations, which are common throughout that area of Virginia.
The local health department was informed of the elevated uranium levels, and a stop drinking water advisory was issued for the hundreds of affected residents. Samples were collected by the Virginia Department of Health (VDH) and submitted to the Division of Consolidated Laboratory Services (DCLS) for analysis. The samples were collected from both wells, and at six households located down gradient. Findings are presented in Table 2 . In the interest of monitoring human health, a voluntary epidemiological assessment was launched in May 2004, with input from a residence advisory group. The purpose of the assessment was to determine the current concentrations of urine uranium in affected residents, and evaluate for potential damage to the participants' kidneys by measuring the low molecular weight proteinFRBP, and then repeat biomonitoring 1 year later. A survey was used to collect pertinent information from each participant to improve interpretation of results (Appendix A). Sampling was carried out in the distribution system (such as at a resident's home) rather than at the wells.
Uranium exposure monitoring in south central Virginia
Materials and methods

Study Population
A primary goal of the investigation was to determine the health effects of exposure to the uranium-contaminated water. As a result, all members of the affected community who volunteered were accepted into the study. This included every member of each household for which samples were submitted. A demographic breakdown of the study population is given in Table 3 . The median length of residence in the two subdivisions was found to be 14 years, with a range of 1 to 27 years. For the sample collection period of May 2004, 196 people participated, and for the collection period of May 2005, 91 residents participated. The reduction of participants is the result of community residents electing not to provide samples for the second round of testing. All of the participants in the second round had submitted samples in the first collection period. The initial sample collection occurred over a three-day period in May 2004, followed by a second round of testing in May 2005. Specimens were analyzed the same day as received at the laboratory for urine uranium, while aliquots for the Belgium laboratory were stored at À801C until shipment. Other nephrotoxic metals that may have been ingested by the participants, for example, dietary cadmium or other metals, were not tested for in the analysis. Sample collection and analysis were performed in the same manner for each test period.
Uranium Intake
Data collected during an interview, see questionnaire attached as Appendix A, conducted when the sample collection kits were distributed, indicated that seven (5%) of the households in the first round of investigation used some type of commercial filtration device commonly sold for domestic use. None of these filter systems were determined to be effective in removing uranium from the tap water, as analysis of pretreatment and post-treatment water was found to contain the same levels of uranium. Ingestion rates were not calculated, but total water consumption was estimated from the questionnaire. All but four individuals drank tap water daily, with an estimated median intake of nine 8 Oz glasses per day. Tap water was also used daily for cooking and making ice, which provided other pathways for exposure.
Measurement of Uranium and pH
Urine specimen collection kits and instructions on sample collection were distributed to each household, (Appendix B). A first-morning void was collected by the participants, sealed, and given to a VDH representative on the same day. Specimens were stored on ice and delivered to DCLS the same day as collection. Specimens were aliquoted for urine uranium, pH, RBP, and creatinine analysis in the laboratory. Urine uranium concentrations were determined using inductively coupled plasma mass spectrometry (ICP/MS) at the Division of Consolidated Laboritories (Richmond, VA). Determination of the pH was also performed at DCLS, using a Thermo Orion model 410 pH meter (Waltham, MA) and a two-point calibration curve.
Quantification of urine uranium was based on a five-point calibration curve. The standards used in the curve were prepared by serial dilution of a 500-mg/l solution (High Purity Standards, Charleston, SC) of uranium. This solution is acidified with 1% v/v HNO 3 , and the calibration curve consists of points at 0.0125, 0.0250, 0.1250, 0.2500, and 0.5000 mg/l. Typical r 2 values are greater than 0.999, indicating changes in the uranium concentration are accurately modeled by a linear regression line. Samples that were found to have uranium concentrations above the high standard on the curve were diluted so that their uranium concentrations would fall on the calibration curve. The analyzed value was then multiplied by the dilution factor to verify that values above the curve were accurately represented. Repeated analysis of diluted samples showed that measurements of uranium concentrations above the high calibration standard were accurate, and dilution was not necessary.
To prepare samples for analysis, 500 ml of sample were diluted with 4.5 ml of internal standard solution. The internal standard solution was a 2% v/v HNO 3 and 10-mg/l iridium mixture in 18 MO H 2 O. The ICP/MS analysis was performed on an Elan DRC II (Perkin Elmer, Wellesley, MA), using a Meinhard nebulizer with a gas flow rate of 0.98 ml/min. The Elan DRC II is operated in Pulse mode, with a dwell time of 15 ms. An argon plasma torch, RF power of 1400 W, dries and atomizes the sample before ionizing it by the removal of an electron. A quadrupole mass spectrometer is then used to filter the ion stream, so that a maximum number of uranium ions are passed onto the detector. The accuracy of the results was verified by running lowand high-level spiked samples of urine. To account for the varying levels of hydration of the study participants, the reported levels of uranium in each sample were normalized using creatinine concentration.
Measurement of RBP and Creatinine
The aliquots for creatinine and RBP were packaged on dry ice and shipped to the Catholic University of Louvain, Department of Industrial Toxicology and Occupational Medicine (Belgium), for analysis. Levels of RBP were determined by latex immunoassay (Bernard et al., 1982) . The aliquots for RBP and creatinine were shipped unbuffered, as previous investigations by Bernard and coworkers indicated that RBP is stable in urine down to a pH of 4.5, and all samples tested were determined to be above this value. The average pH was 5.9, with a range of 5.0 to 8.1.
Creatinine was determined by the Jaffe method (Slot, 1965; Seation and Ali, 1984) . The creatinine present in the urine is reacted with an alkaline picrate to produce a red color. The intensity of the resulting red color is directly proportional to the concentration of creatinine in the urine. A spectrophotometer is used to measure the absorbance at 505 nm, which can be plotted versus creatinine concentration to create a calibration curve. Samples with an unknown concentration of creatinine are reacted with alkaline picrate, and their absorbance is measured. The linear regression equation obtained from the calibration curve is used to calculate the creatinine concentration of the sample.
Statistical Methods
Individual results obtained for urinary uranium concentrations, normalized to creatinine concentration, are presented as a geometric mean. Samples determined to be below the detection limit of 0.002 mg/l were not included in statistical treatments of the data. RBP results were treated in the same manner. One participant in the study was determined to have a pre-existing condition that resulted in extremely high values of RBP being detected in their urine samples, and was excluded from the calculation of the geometric mean.
Results
During the first round of testing in May 2004, 156 specimens were collected from 62 households. Seventy-five percent of the specimens were considered to have elevated concentrations of uranium, as defined by the sample exceeding the 95th percentile of the CDC Third National Report on Human Exposure to Environmental Chemicals (CDC, 2001 (CDC, -2002 . In round one, eight samples were above 1.0 mg/g creatinine. The CDC Third National Report on Human Exposure to Environmental Chemicals lists values of urine uranium found in a subset consisting of 2700 US civilian non-institutinonalized people age 6 years and older. In the report, the geometric mean for urine uranium was 0.008 mg/g creatinine, with a 95% confidence level of 0.007 to 0.009 mg/g creatinine. For NHANES, the 95th percentile for urine uranium was 0.046 mg/g creatinine, ranging from 0.036 to 0.054 mg/g creatinine. The geometric mean for samples tested in round one was 0.100 mg/g creatinine.
In the second round of testing, the number of specimens decreased to 91 from 156 (58%), due to participant attrition. In this round of testing, only one participant was found to have an elevated level of uranium, 0.445 mg/g creatinine; however, this represents a 39% reduction from this person's initial result. A majority, 53 of 91 (58%), of participants had a urine uranium level below the limit of detection, in contrast to the first round in which all 156 participants had a measurable quantity of urine uranium. All 91 of the secondround participants had urine uranium concentrations below 1.0 mg/g creatinine. The geometric mean for the second round dropped to 0.011 mg/g creatinine. Results for both testing periods are listed in Table 4 .
Normal functioning kidneys will produce RBP, which is reabsorbed back into the kidney; however, some RBP is excreted into the urine, with typical levels not exceeding 300 mg/g creatinine. Individuals with RBP values in the range of 300 to 1000 mg/g creatinine may be in the initial stages of damage to their proximal tubule; however, this damage is Uranium exposure monitoring in south central Virginiaconsidered reversible if exposure is stopped. RBP concentrations of 1000 to 10,000 mg/g creatinine indicates irreversible damage, with concentrations greater than 10,000 mg/g creatinine being a sign of severe damage, and accompanies a decrease in kidney filtration rate. (USDHHS, 2002) . As an early indicator of possible damage, RBP levels can be monitored with elevated levels indicating poorly functioning proximal tubules. Results are presented in Table 5 . Only those participants that were found to have elevated levels of RBP, above 300 mg/g creatinine, were tested for RBP again in round two. Only four of the original 156 participants met this criterion. Of these four; one had an RBP output in excess of 100,000 mg/g creatinine, and the remaining three specimens were near or below 300 mg/g creatinine after the second round. The individual, whose RBP output exceeded 100,000 mg/g creatinine, was determined to have a preexisting condition that resulted in kidney damage, causing the high RBP values. Data from this individual were excluded from all calculations.
Discussion
This unique community-based, 12-month uranium biomonitoring investigation of rural Virginians exposed to uranium in drinking water found consistent reductions in levels of urine uranium after a public health intervention was implemented. This population was ingesting water either at or two times above the EPA MCL for uranium, according to recent analysis results of groundwater wells. At baseline, average and median urine uranium levels were an order of magnitude above levels seen in US population studies. Twelve months later, geometric average urine uranium concentrations dropped by one order of magnitude among the 91 participants re-sampled, and 58% of these participants had a urine uranium level below the detection limit for uranium, indicating that significant amounts of uranium were excreted from the body after the source of the uranium exposure was mitigated. Study strengths include the involvement of local residents in developing the survey tool and specimen collection schedule, communicating the study's benefits, and residents' study participation. A limitation was that doses for any particular individual, as well as water system operational logs were not available; therefore, some exposure assumptions had to be made. On initiation of the study, residents were provided with emergency, potable water supply and an anion-exchange filtration system was established to ensure safe drinking water. The system was designed by Water Remediation Technology, LLC, (WRT) and has a capacity of 80 gpm. The overall cost of the system was $40,700, which included a building for housing the treatment station, installation of pipes, and start-up fees. WRT charges an additional annual fee for replacement and disposal of the anion-exchange media, which is a proprietary compound. 
